An anonymous reader quotes a report from ABC News: Alpha-gal syndrome (AGS) is a serious, potentially life-threatening allergic reaction that arises after people eat red meat or consume products with alpha-gal, a type of sugar found in most mammals, th…

An anonymous reader quotes a report from the Washington Post: A study published Monday in the Lancet found that the use of hearing aids can reduce the risk of cognitive decline by about half — 48 percent — for adults with more risk factors for dement…

An experimental drug can slow progression of Alzheimer’s disease in those who start taking it when the disease is still in its early stages. Nature: The drug, a monoclonal antibody called donanemab, does not improve symptoms. But among people who start…

An anonymous reader quotes a report from Scientific American: Constant buzzing and ringing in the ears without any input from the external environment can seriously impair quality of life for the 10 percent of the U.S. population with severe tinnitus. …

The U.S. Food and Drug Administration (FDA) disagrees with the World Health Organization’s recent assessment that aspartame possibly causes cancer in humans. “Aspartame is one of the most studied food additives in the human food supply. FDA scientists …

An anonymous reader quotes a report from the New York Times: A World Health Organization agency declared on Thursday that aspartame, an artificial sweetener widely used in diet drinks and low-sugar foods, could possibly cause cancer. A second W.H.O. co…

“The flow of lifesaving organs to 63 U.S. transplant centers could be disrupted…” reported the Washington Post on Monday, “by a dispute over the use of data.”

Or, as a local news station WRIC puts it, “Two entities dedicated to fighting to save liv…

An anonymous reader quotes a report from Harvard Medical School: Scientists have designed an AI tool that can rapidly decode a brain tumor’s DNA to determine its molecular identity during surgery — critical information that under the current approach …

An anonymous reader quotes a report from Politico: The FDA on Thursday granted traditional approval to an Alzheimer’s drug for the first time in more than two decades. Now, the question becomes how many people will be able to access the drug, which is …